CHINA EB LTD

165
4.4751.00% ( -0.045 )
Delay Closed: Nov 16, 16:08:11

Overview

CHINA EB LTD (165)

China Everbright Limited provides financial services in Hong Kong, Mainland China, and internationally. It operates through Fund Management Business and Princip...

Open
4.540
High
4.575
Low
4.405
Prev. Close
4.520
Volume
5.93M
Turnover
26.61M
Avg Price
4.490
Bid/Ask Ratio
20.00%
Amplitude
3.76%
52wk High
11.170
Volume Ratio
1.07
Turnover Ratio
0.35%
52wk Low
4.405
HK Mkt Cap
7.54B
Market CapHKD
7.54B
P/ETTM
Loss
P/EDynamic
Loss
P/EStatic
--
EPSTTM
-2.65
EPSDynamic
-2.44
EPSStatic
--
BVPS
15.01
P/B
0.30
HK Shares
1.69B
Dividend YieldTTM
2.01%
DividendTTM
0.09
Shares
1.69B
Min lot size
2,000
Currency
HKD

CHINA EB LTD Analyst Rating

View more

Forecast & Rating

Aug 28, 2026
Price forecast
HK$8.0078.77%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Nov, 9

    China Everbright (165.HK) reversed early gains, touching HK$5.12 in the morning session before sliding to HK$4.75 at 15:01 BJ, matching its 52-week low, and closing at HK$4.805, down 4.0% on 11.75 million shares worth HK$57.2 million. CITIC-Prudential Life Insurance cut 1.72 million shares at about HK$5.03, adding supply just as the stock printed a fresh 52-week low. Fundamentals reinforce the drift: Q2 2026 revenue of HK$691.4 million fell 26.28% yoy, net loss reached HK$1.03 billion (down 615.91% yoy), EPS was -HK$0.6112, with PB at 0.32x and PE at -1.81x. The shares are down 49.42% year to date, 57.33% below the January 12 high of HK$11.26, and sit under MA20 at HK$5.32 and MA60 at HK$5.87. An appeal in the RMB1.88 billion equity-transfer dispute with Yingli International Property was accepted and CGS International kept a Buy rating, though neither has changed the tape.

  2. Nov, 6

    China Everbright (165.HK) reversed early gains to close at the session low of HK$4.945, down 7.1% from the prior HK$5.325 close on HK$330mn turnover, after peaking at HK$5.220 at 10:35 BJ; the slide followed disclosure that CITIC-Prudential Life cut 1.72 million shares at about HK$5.03, prompting profit-taking after the stock's 5% rebound a week earlier. The operating backdrop remains weak: Q2 revenue fell 26.28% year on year to HK$691mn and net profit swung to a HK$1.03bn loss (-615.91% YoY), leaving ROE at -12.68%, PE at -1.87 and PB at 0.33 on an HK$8.33bn market cap. The stock is down 47.95% year to date, sits 56.08% below its 52-week high of HK$11.26 and just 0.71% above its 52-week low of HK$4.91, below both the MA20 of HK$5.38 and MA60 of HK$5.892. CGS International nonetheless keeps a Buy rating, while the 1.82% dividend yield offers only modest cushion.

  3. Oct, 22

    China Everbright (165.HK) spiked then faded, opening at the session high of HK$5.420 and grinding down to HK$5.075 by 15:54 BJ, closing at HK$5.115, roughly 6.2% below the prior close of HK$5.455 on 6.89m shares worth HK$35.7m. The interim result's HK$2.17bn litigation charge drove a HK$1.87bn net loss even as turnover rose 60.26% to HK$4.49bn, with EPS at -HK$0.6112 and net margin -142.79%, while the RMB1.88bn equity-transfer dispute with Yingli International Property remains on appeal. The stock now sits just 0.89% above its 52-week low of HK$5.07, down 46.16% year-to-date and well below the MA20 of HK$6.016 and MA60 of HK$6.056, with PB 0.34x and PE -1.93x. CGS International and CSC Financial keep Buy ratings, though that has not visibly stemmed the drift.

  4. Oct, 9

    China Everbright (165.HK) closed at HK$5.97, down about 3.0%, in a session that opened lower, spiked to HK$6.215 early, sank to HK$5.83 before midday and recovered to HK$6.01 in the afternoon on roughly HK$61 million turnover. The pressure traces to interim results showing a net loss of HK$1.87 billion, including HK$2.17 billion of litigation expense, even as turnover rose 60.26% to HK$4.49 billion and the interim dividend was cut to HK$0.04 per share. CGS International and CSC Financial kept Buy ratings, yet the stock sits below its 20-day (HK$6.239) and 60-day (HK$6.093) moving averages, down 37.16% year-to-date and 53.79% below the HK$12.92 52-week high. Valuation shows 0.40x price-to-book, negative 2.25x P/E and about HK$10.06 billion market cap. Though the top-line expansion and maintained ratings leave room to watch for a turnaround.

  5. Sep, 28

    中国光大控股今日下午盘大幅拉升,全日收涨 5.05% 至 6.440 港元,主要受此前公布的 2026 年上半年财报超六成营收增长及 CSC Financial 维持买入评级的提振,但期间公司计提 17.4 亿港元诉讼费用导致净亏损达 18.7 亿港元,EPS 为-0.6112 港元同比暴跌 615.78%。盘中上午盘一度探底至 6.105 港元创日内低点,下午盘则单边上行触及 6.450 港元高点,最终收于 6.440 港元,逼近日内高位。当前股价较 52 周高点 13.24 港元仍跌 51.36%,但已站上 20 日均线 (6.283 港元) 和 60 日均线 (6.014 港元),YTD 跌 32.21%。不过,公司净利率降至-142.79% 且利润端持续巨亏,基本面压力仍存。

News

Bullish vs. Bearish — Last 3 Months

4.3k followers · 0 opinions
▲Bullish50%
50%Bearish▼